Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

APIs

The Story Of India’s Economic Pushback Against China
The Story Of India’s Economic Pushback Against China Tushar GuptaJul 14, 2022 01:17 PM +05:30 IST
Local Manufacturing Of 35 APIs Under PLI Scheme Underway As India Seeks Atmanirbharta In Pharma Sector By Reducing Imports From China
Local Manufacturing Of 35 APIs Under PLI Scheme Underway As India Seeks Atmanirbharta In Pharma Sector By Reducing Imports From China Swarajya StaffMar 30, 2022 10:11 AM +05:30 IST
Why Are Brokers Opposing SEBI’s Regulations In Algo Trading?
Why Are Brokers Opposing SEBI’s Regulations In Algo Trading?Sourav DattaDec 14, 2021 01:22 PM +05:30 IST
Glenmark Life Sciences IPO: Should You Subscribe? Strong Player In APIs With Focus On Contract Development and Manufacturing
Glenmark Life Sciences IPO: Should You Subscribe? Strong Player In APIs With Focus On Contract Development and ManufacturingSourav DattaJul 29, 2021 11:13 AM +05:30 IST
Pharma Sector: Approvals Accorded Under PLI Scheme For Rs 348 Crore Investment In Drug Intermediates And APIs
Pharma Sector: Approvals Accorded Under PLI Scheme For Rs 348 Crore Investment In Drug Intermediates And APIsSwarajya StaffApr 14, 2021 11:20 AM +05:30 IST
Pharma Sector: Union Govt Approves Investments Of Rs 5,082 Crore Under PLI Scheme For APIs
Pharma Sector: Union Govt Approves Investments Of Rs 5,082 Crore Under PLI Scheme For APIsSwarajya StaffMar 12, 2021 12:27 PM +05:30 IST
Explained: Rs 15,000 Crore PLI Scheme For Pharmaceutical Companies That Aims To Achieve 'Atmanirbharta' In APIs And High-End Medicines
Explained: Rs 15,000 Crore PLI Scheme For Pharmaceutical Companies That Aims To Achieve 'Atmanirbharta' In APIs And High-End MedicinesSwarajya StaffFeb 25, 2021 08:31 AM +05:30 IST
Indian Drug Makers Embrace 'Go Local' Mantra For APIs As They Seek To Reduce Dependence On China For Raw Materials
Indian Drug Makers Embrace 'Go Local' Mantra For APIs As They Seek To Reduce Dependence On China For Raw MaterialsSwarajya StaffFeb 24, 2021 09:50 AM +05:30 IST
Govt To Set Up Three Bulk Drug Parks For Manufacturing Of APIs, To Invest Rs 14,300 Crore
Govt To Set Up Three Bulk Drug Parks For Manufacturing Of APIs, To Invest Rs 14,300 CroreIANSJan 2, 2021 08:12 AM +05:30 IST
Pharma Sector Seeks Urgent Clearance For APIs, Medical Devices Imported From China
Pharma Sector Seeks Urgent Clearance For APIs, Medical Devices Imported From ChinaIANSJun 29, 2020 02:25 PM +05:30 IST
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth Karan BhasinApr 16, 2020 03:50 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype